. . . While Zimmer Looks Out
Executive Summary
Orthopedic implant companies are struggling with pricing pressures and new customer demands, and one company, market leader, Zimmer has responded with a major shake-up of top management. The question industry watchers are asking: does Zimmer's move represent the first step in a major retrenchment in orthopedics for Bristol-Myers Squibb? Or the beginning of a new, more aggressive effort?